Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Alterations of the optic pathway between unilateral and bilateral optic nerve damage in multiple sclerosis as revealed by the combined use of advanced diffusion kurtosis imaging and visual evoked potentials.
Dimethyl fumarate inhibits the expression and function of hypoxia-inducible factor-1α (HIF-1α).
Dimethyl Fumarate Ameliorates Lewis Rat Experimental Autoimmune Neuritis and Mediates Axonal Protection.
Data supporting the role of Fyn in initiating myelination in the peripheral nervous system.
Synaptic pathology: a shared mechanism in neurological disease.
Compliance to fingolimod and other disease modifying treatments in multiple sclerosis patients, a retrospective cohort study.
Generation of demyelination models by targeted ablation of oligodendrocytes in the zebrafish CNS.
Laquinimod in Relapsing-Remitting Multiple Sclerosis
A Cross-Sectional Study of the Impact of Spasticity on Daily Activities in Multiple Sclerosis.
Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome.
Interferon-beta-1b protects against multiple sclerosis-induced endothelial cells apoptosis.
Development of a recombinant immunotoxin for the immunotherapy of autoreactive lymphocytes expressing MOG-specific BCRs.
Genentech and Biogen Idec announce top-line results from a Phase II/III clinical trial of Rituxan in primary-progressive multiple sclerosis
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity.
CHMP determines dimethyl fumarate in TECFIDERA® to be a new active substance in the European Union
Patient trial of immunization to treat Alzheimer’s disease begins at Cedars-Sinai
Relationship between neuromuscular and perceived fatigue and locomotor performance in patients with multiple sclerosis.
Will the real multiple sclerosis please stand up?
Zebrafish: A new vertebrate model for visualizing myelination in vivo.
Diagnosis and treatment of hyponatraemia.
Morphogenesis of the demyelinating lesions in Baló's concentric sclerosis.
Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis.
Magnetic resonance imaging outcomes from a phase III trial of teriflunomide.
Genzyme Announces Successful Phase III Results for Alemtuzumab (LEMTRADA TM*) in Multiple Sclerosis
Peripheral Bilateral Telangiectasiae in Multiple Sclerosis Patients Treated with Interferon B1a.

Pages